May 11-14, 2026 | boston, MA, US. Alira Health Group is proud to attend TIDES USA, an event focused on accelerating oligo, peptide, and mRNA therapeutics to market with leading R&D, manufacturing, and CMC strategists onsite. Take this opportunity to connect with its delegates and explore its comprehensive range of services. Its CMC experts help clients navigate the complex demands of product development and Alira Health Group support strategic activities in areas like manufacturing and operations, process development and optimization, CDMO selection, and quality and regulatory affairs. Meet its delegates. Sean Forestell Senior Vice President, CMC Operations Andrew Moore Senior Vice President, Commercial Alira Health Group can help you navigate the complex demands of product development. Its team of subject matter experts will work closely with you to guide you through the most demanding projects.

WCCC Driving Innovation in Wound Care Summit 2026. April 10, 2026 | charlotte, NC, US. Alira Health Group is proud to attend the Driving Innovation in Wound Care Summit, co-located with SAWC Spring and hosted by the Wound Care Collaborative Community (WCCC). Alira Health Group is excited to connect with key opinion leaders and colleagues in research, clinical practice, industry, health systems, and payers to discuss overcoming the barriers to wound care innovation. Look for Gabriele Brambilla as a presenting Faculty speaker for the panel "The Power of Patient Voices & Developing PROs." Gabriele is the CEO of Alira Health and Chair of its Wound Care Center of Excellence. Connect onsite with him to learn how Alira Health Group support the development of high-quality solutions across acute and non-acute care settings. Alira Health Group offer more than 20 years of experience in wound care technologies. As the first Platinum CRO Partner of the WCCC, Alira Health Group is proud to attend and speak at this exciting event. About panel session, "the Power of Patient Voices & Developing PROs" Session Time: 10:30-11:15 AM This panel centers on the lived experience of patients with chronic wounds to inform the development and meaningful use of patient-reported outcomes (PROs) in clinical trial design. Bringing together patients, clinicians, FDA representatives, and industry leadership, the discussion explores how patient priorities can be systematically translated into credible, actionable endpoints that strengthen regulatory decision-making and improve the real-world relevance of clinical evidence. * Gabriele Brambilla, MBA, Alira Health * Windy Cole, DPM, Director of Wound Care Research, Kent State University * Holly Franzen-Korzendorfer, PhD, PT, Clinical Assistant Professor of Physical Therapy, Marist University Meet its speaker. Gabriele Brambilla Chief Executive Officer and Chair, Wound Care Center of Excellence Gabriele Brambilla, MBA, is the CEO and co-founder of Alira Health. As Chair of the Alira Health Wound Care Center of Excellence, he pioneers data-driven, multidisciplinary solutions that address critical challenges. His vision shapes Alira Health's integrated approach, advancing therapies and technologies for transformative impact in the wound care sector. Gabriele is also a leading advocate for the local and global growth of life sciences. In 2018, he co-founded the MetroWest Life Sciences Network, a nonprofit regional collaboration of healthcare and life science-based organizations, and as the network's current chairman, Gabriele fosters collaboration, innovation, and entrepreneurship in this critical life sciences ecosystem. In conjunction with this, he sits on the Board of Directors of MassMedic, EnlightenVue, WoundForce, Firefly Innovations, X-Cor Therapeutics, Computational Life and Oncoheroes. Gabriele holds a BA in Political Science from the University of Pavia, a master's degree in International Affairs from the I.S.P.I., and an MBA from Post Graduate SDA Bocconi in Milan, Italy. With exclusive access to critical patient data and deep industry expertise, Alira Health Group work with you to transform the wound care industry and deliver meaningful outcomes for patients.

PHUSE US Connect 2026. March 22 - 26, 2026 | austin, TX, US. Alira Health Group is excited to attend and sponsor PHUSE US Connect 2026, an event that brings together the clinical data science community for a week of innovation, collaboration, and fresh perspectives. During the event, Alira Health biometrics experts will lead a hands-on workshop, "The Role of Standards in a World of Agentic AI," in collaboration with its partner Medidata. Join its workshop and meet its team to learn how Alira Health Group help you reduce risk, streamline submissions, and approach regulatory review with confidence - by working as a true extension of your team. About its Hands-on Workshop "the Role of Standards in a World of Agentic AI" Date: March 24 | 4:00 PM Agentic AI is crashing the clinical research party - and it didn't bother to read the CDISC standards first. As both regulators and industry start experimenting with AI agents that can think, reason and even code, Alira Health Group is faced with a provocative question: if machines can interpret context, do they still need its tables? Its industry loves structure - SDTM, ADaM and Define-XML are practically comfort food. But large language models don't think in columns and rows. So what happens when its AI 'colleague' skips straight from raw data to validated results without generating any of those beautiful interim datasets Alira Health Group has spent years perfecting (and years debugging)? In this Hands-on Workshop, Alira Health Group'll: * Play with agentic AI tools that automate clinical data transformations * Debate what happens to standards, traceability and sanity when its 'junior programmer' is an AI agent that never sleeps * Challenge its assumptions about what 'standards' mean in an AI-driven world. Are Alira Health Group witnessing the evolution of clinical data workflows? Or their total disruption? Come ready to code, question, and maybe commit a few heresies. By the end, you'll have a clearer view of how AI could upend its current data standards - and whether that's brilliant, terrifying, or a little bit of both. Workshop facilitator. Paula has been in the industry for over 30 years as a statistician, programmer, business portfolio manager and mentor in pharma, biotech and CRO companies. She has a strong track record in leading teams to deliver the statistical and programming aspects of clinical research projects from conception to completion whilst ensuring quality and regulatory compliance. Meet its delegates. Angelica Borgo Business Developer, Biometrics General In this Q&A, Alira Health Group explain why SEND matters for regulatory submissions, what timelines and requirements sponsors must follow, and how SEND readiness can help to prevent costly delays. Discover Alira Health's best practices for a successful data monitoring committee, with a strong focus on the Independent Statistical Center.